034940 — ChoA Pharmaceutical Co Balance Sheet
0.000.00%
- KR₩31bn
- KR₩52bn
- KR₩63bn
Annual balance sheet for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9,065 | 10,214 | 6,996 | 4,415 | 5,472 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 25,054 | 24,932 | 27,623 | 23,908 | 20,971 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 47,350 | 46,504 | 48,200 | 42,157 | 39,740 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22,190 | 24,074 | 24,999 | 20,370 | 19,712 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 82,377 | 80,512 | 85,639 | 74,221 | 71,320 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19,178 | 24,263 | 27,328 | 29,178 | 36,656 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 24,075 | 30,592 | 32,796 | 33,228 | 39,944 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 58,302 | 49,920 | 52,844 | 40,993 | 31,376 |
Total Liabilities & Shareholders' Equity | 82,377 | 80,512 | 85,639 | 74,221 | 71,320 |
Total Common Shares Outstanding |